(Q34615900)

3 August 2017

1 reference

title

How predictive is PK/PD for antibacterial agents? (English)

1 reference

3 August 2017

1

Niels Frimodt-Møller

1 reference

3 August 2017

publication date

1 April 2002

1 reference

International Journal of Antimicrobial Agents

3 August 2017

published in

1 reference

3 August 2017

volume

19

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

333-339

1 reference

"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Effect of schedule of administration on the therapeutic efficacy of penicillin; importance of the aggregate time penicillin remains at effectively bactericidal levels

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Pharmacokinetic Determinants of Penicillin Cure of Gonococcal Urethritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Single injection treatment of meningococcal meningitis 1. Long-acting penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Penicillin in the treatment of streptococcal infections; a comparison of effectiveness of five different oral and one parenteral form

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Intramuscular ceftriaxone compared with oral amoxicillin-clavulanate for treatment of acute otitis media in children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Randomized study of single-dose, three-day, and seven-day treatment of cystitis in women

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Single-dose antimicrobial therapy for urinary tract infections in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Antibiotic efficacy in vivo predicted by in vitro activity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

In vivo postantibiotic effect in a thigh infection in neutropenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

Modeling the response of pneumonia to antimicrobial therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900029-8

7 January 2021

10.1016/S0924-8579(02)00029-8

Identifiers

DOI

1 reference

release_qo4tqrunprbgzlndfcnklumkqe

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qo4tqrunprbgzlndfcnklumkqe

24 November 2022

mapped directly with Wikidata item

1 reference